Immune Checkpoint Inhibitors (ICIs) Retreatment in Second-line Treatment of Advanced Gastric Cancer: a Retrospective, Real-world Study

Clinical trial NCT06814548 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06814548
Sponsor: Yongxu Jia
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Gastric Cancer, Gastroesophageal Junction Cancer Immune Checkpoint Inhibitors (ICIs)Second-line Retreatment

Start date: 2025-02-10
Primary completion: 2025-05-31
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.